US BANCORP \DE\ - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 213 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$35,550
-42.8%
773
-28.5%
0.00%
Q2 2023$62,125
-50.7%
1,081
-67.8%
0.00%
Q1 2023$125,926
+36.2%
3,358
+1.8%
0.00%
Q4 2022$92,466
+32.1%
3,300
+32.4%
0.00%
Q3 2022$70,0000.0%2,492
+23.2%
0.00%
Q2 2022$70,000
+42.9%
2,023
+49.5%
0.00%
Q1 2022$49,000
+58.1%
1,353
+3.3%
0.00%
Q4 2021$31,000
+40.9%
1,310
+12.8%
0.00%
Q3 2021$22,000
-4.3%
1,1610.0%0.00%
Q2 2021$23,000
+9.5%
1,1610.0%0.00%
Q1 2021$21,000
-12.5%
1,161
-2.6%
0.00%
Q4 2020$24,000
+4.3%
1,1920.0%0.00%
Q3 2020$23,000
-68.9%
1,192
-63.8%
0.00%
Q2 2020$74,000
+335.3%
3,294
+183.7%
0.00%
Q1 2020$17,000
-37.0%
1,161
-17.0%
0.00%
Q4 2019$27,000
+800.0%
1,398
+898.6%
0.00%
Q1 2019$3,000
-98.1%
140
-98.5%
0.00%
-100.0%
Q2 2015$159,000
+12.8%
9,055
-3.6%
0.00%0.0%
Q1 2015$141,000
+20.5%
9,395
-6.6%
0.00%
Q4 2014$117,00010,0600.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
FRIESS ASSOCIATES LLC 97,760$3,401,0005.68%
Nantahala Capital Management 1,000,000$34,790,0001.74%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 341,294$11,874,0001.52%
Portolan Capital Management 274,889$9,563,0000.96%
Quantedge Capital Pte Ltd 121,500$4,227,0000.85%
SHAKER INVESTMENTS LLC/OH 37,117$1,291,0000.82%
GLOBEFLEX CAPITAL L P 72,253$2,514,0000.61%
EAM Investors, LLC 68,855$2,395,0000.58%
Hillsdale Investment Management Inc. 197,738$6,879,0000.55%
Capital Impact Advisors, LLC 13,835$481,0000.44%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders